Purpose : To compare basal and clomiphene citrate (CC) induced follicle-stimulating hormone (FSH), estradiol (E 2 ), and inhibin B levels with ultrasound indices of ovarian reserve in infertile women and to test the prognostic value of these tests on response to ovarian stimulation in in vitro fertilization (IVF). Methods : Fifty-six patients had basal and CC induced serum hormone levels and ultrasound measured mean ovarian volume (MOV) and mean antral follicle counts (MFC). Thirty-two patients were then appropriately selected to have a total of 41 cycles of IVF/ICSI treatment. Results : Women with diminished ovarian reserve had lower MOV, MFC, day 3 and day 10 inhibin B levels ( p < 0.001). Only basal and CC induced FSH and inhibin B correlated with MOV and MFC. Poor responders in IVF/ICSI had higher basal FSH ( p < 0.05), lower basal and induced inhibin B levels ( p < 0.05), and lower MOV and MFC ( p < 0.01) than normal responders. Ovarian volume alone was better than age and basal hormones in predicting poor ovarian response, while abnormal CC test was the only independent significant factor in predicting ovarian response. However, age was the only independent predictor of pregnancy in IVF as compared to hormonal and ultrasound indices of ovarian reserve. Conclusion : CC test and ovarian volume are better than other hormonal and sonographic tests in predicting the response to ovarian stimulation in IVF cycles.
INTRODUCTION
Diminished ovarian reserve occurs physiologically with age or occasionally before mid 30s. Prediction of ovarian reserve is important in women who desire fertility in their late 30s and early 40s at a time when their reproductive performance is declining. It is also 1 IVF Unit and Department of Obstetrics and Gynecology, University of Gazi, Ankara/Turkey. 2 To whom correspondence should be addressed at Bilkent III, Ufuk Sitesi, F3 Daire, 12, 06530, Ankara-Turkey; e-mail: erdemom@yahoo.com.
important to predict whether an infertile woman still has sufficient ovarian reserve before beginning a fertility treatment, especially where multiple follicular development plays a major role in the successful outcome of the treatment, like IVF-ET. A variety of techniques have been evaluated to assess "ovarian reserve" in infertile women. Basal serum follicle-stimulating hormone (FSH) and estradiol (E 2 ) measurements have been used as outcome predictors for superovulation cycles to measure ovarian responsiveness to stimulation with gonadotropins and to predict pregnancy rates (1) (2) (3) . Basal FSH measurement is an indirect test to predict remaining number of follicles, i.e. ovarian reserve, in the ovary. The prognostic value of this test is limited with low predictive value of a normal test and significant intercycle variability (2, (4) (5) (6) (7) . Although FSH response to clomiphene citrate (CC), i.e. clomiphene citrate challenge test (CCCT), has been suggested to predict ovarian reserve better than cycle day 3 FSH, it is also an indirect measurement of ovarian reserve (2) . Inhibin B is produced mainly by granulosa cells of the small developing follicles and measurement of its serum concentration may offer a direct assessment of ovarian reserve (8, 9) . There is evidence that follicular phase inhibin B correlates inversely with both age and follicular phase FSH in perimenopausal women (10) . Recent reports have demonstrated normal basal FSH but decreased serum inhibin B concentrations in women with poor ovarian responsiveness and clinical outcomes in assisted reproduction treatment cycles (11, 12) . Others have failed to find clinical value for inhibin B as an ovarian reserve test (13) .
Transvaginal ultrasound (TVUS) measurement of early follicular phase ovarian antral follicle counts and ovarian volume has been used to predict the response to ovulation induction (14) (15) (16) . There is also evidence that a direct relation exists between decreased ovarian volume, antral follicle counts and diminished ovarian reserve (17, 18) . Previous studies have assessed the relations of basal FSH with ovarian antral follicle counts and ovarian volume as well as basal FSH with basal inhibin B to predict ovarian reserve (18) (19) (20) (21) . Comparison of basal inhibin B with ovarian antral follicle counts and ovarian volume and other basal and CC induced hormonal parameters of ovarian reserve, to our knowledge, has not been previously reported.
The purpose of this study was to compare basal and CC induced FSH and inhibin B levels with transvaginal ultrasound measurement of basal antral follicle counts and ovarian volume as an ovarian reserve test in a group of infertile women and to test the prognostic value of these results on response to ovarian stimulation in assisted reproduction treatment.
MATERIALS AND METHODS

Subjects and Study Design
The study included 56 infertile patients referred to our "Infertility and IVF Clinic" for infertility therapy from January 2000 to December 2000. Our inclusion criteria were infertile women in all ages with 1) regular menstrual cycles (21-35 days) 2) no endocrine disorders (polycystic ovarian syndrome or polycystic ovaries on ultrasonography, normal thyroid function tests, and serum prolactin levels), 3) intact ovaries visible on ultrasonography. All patients had transvaginal ovarian ultrasound measurements on cycle day 3 using an Aloka SSD-1000 (Japan) with a 5 MHz transvaginal probe. After the localization of both ovaries in a longitudinal section adjacent to the iliac vessels, round or oval sonoluscent structures in the ovaries were regarded as follicles. Follicles measuring less than 8 mm. were counted from the lateral to the medial margin of the ovary to determine the antral follicle cohort. The average of the total number of follicles per patient counted on both ovaries were used for calculations. The volume of each ovary was calculated by measuring the three perpendicular diameters (longitudinal, anteroposterior, and transverse) and applying the formula for an ellipsoid (0.523 × length × height × width) as described before (22) . Mean ovarian volume was the mean volume calculated for both ovaries in the same woman. Transvaginal ultrasound measurements were always performed by the same authors (ME and AE).
As a part of their routine infertility evaluation, cycle day 3 serum sampling was followed by administering clomiphene citrate 100 mg per day from cycle day 5 to day 9 for CCCT and resampling on day 10 for both basal and stimulated serum FSH and E 2 measurements. Day 3 and day 10 serum samples were also stored at −20
• C until assayed for inhibin B in a single batch. A cycle day 3 or day 10 FSH level ≥10 mIU/mL. was regarded as abnormal (23) . Patients with basal FSH levels >18 mIU/mL or clinical and sonographic signs of polycystic ovaries ( i.e. >10 follicles, peripherally located and smaller than 10 mm. and increased ovarian stromal density) were not included in this study.
After a complete infertility evaluation of 56 patients, 32 patients with different etiologies (tubal 31.3%, male 25.0%, unexplained 37.5% and others 6.2%) were then appropriately selected to have a cycle of IVF/ICSI treatment. Of the remaining 24 patients, five patients were excluded from IVF/ICSI treatment as they were over 45 years of age and/or had basal or CC induced day 10 FSH >18 mIU/mL; 8 patients with male factor or unexplained infertility were selected for controlled ovarian hiperstimulation plus intrauterine insemination with husband sperm; and other 11 patients deferred their therapy for various reasons. In accordance with long luteal suppression protocol, 1 mg of s.c. leuprolide acetate (Lucrin-Abbot) beginning at day 21 of the previous cycle was reduced to 0.5 mg after an adequate ovarian suppression achieved. Stimulation protocol included four to eight ampoules of exogenous gonadotropins, either recombinant or urinary FSH only or in combination with hMG, administered on an individual basis according to the ovarian response. Patients then received hCG when there were two or more follicles >18 mm in diameter with accompanying follicles >14 mm and an adequate E 2 response. Cycles were cancelled when there were three or less dominant follicles (>14 mm.) in spite of adequate gonadotropin stimulation. Poor responder was defined when cycles were cancelled, less than 5 MII oocytes were retrieved and/or hCG day E 2 level was <1000 pg/mL. Transvaginal ovum pick up was performed 35 h after hCG administration under the ultrasound guidance. Embryo transfer (ET) was performed 72 h after ovum pick-up. Up to 4 embryos were replaced and all patients received transvaginal micronized progesterone (Progestan-Koçak, Turkey) 200 mg three times daily until a pregnancy test was performed 12 days after ET. A clinical pregnancy was confirmed by increasing β-hCG concentrations and sonographic evidence of intrauterine gestational sac after ET.
Hormonal Assays
FSH levels were measured by chemoluminescent immunometric assay with intraassay and interassay coefficients of variation of 2.5% and 6.3%, respectively and E 2 levels were measured by competitive immunoassay with intraassay and interassay coefficients of variation of 4.3% and 6.7%, respectively by using Immulite 2000 (Diagnostic Products Corporation, Los Angeles, CA) analyzer. Inhibin B was analyzed in duplicate using a solid phase sandwich enzyme-linked immunosorbent assay (Serotec, Oxford, UK). The as- say sensitivity was <15 pg/mL with interassay and intraassay coefficients of variation <7%.
Statistical Analysis
All data were analyzed by the use of SPSS (SPSS Inc., Chicago, IL) software program. Hormone levels were normally distributed among study groups and comparison of mean serum hormone levels and ultrasound measurements between women with normal and diminished ovarian reserve as well as poor and normal responders were performed with unpaired t test. X 2 test was used for the comparison of clinical pregnancy rates between different subgroups. Pearson's correlation was used to examine the associations between continuous variables. Multiple logistic regression analysis was used to determine the effect of variables (age, basal FSH, basal inhibin B, mean ovarian volume, and antral follicle counts) as determinants of ovarian response. ROC analysis was used to analyze the predictive accuracy of variables. Results are expressed as mean ±SD. A p value of <0.05 was considered significant for all analysis.
RESULTS
A total of 56 patients with a mean age of 34.7 ± 5.5 (range 19-45) had basal and CC induced FSH, E 2 and inhibin B levels and underwent baseline ultrasound examination for mean ovarian volume (MOV) and mean antral follicle counts (MFC). Patient characteristics, basal and CC induced hormone levels and ultrasound indices of ovarian reserve in patients with normal and abnormal CC test were summarized in Table I . Women with normal ovarian reserve were younger as compared to women with diminished ovarian reserve. Day 3 and day 10 inhibin B levels were higher in women with normal ovarian reserve as compared to women with diminished ovarian reserve. Day 3 and day 10 E 2 concentrations did not differ in either group. Patients with diminished ovarian reserve had significantly lower MOV and MFC.
We correlated not only basal and CC induced day 10 inhibin B levels but MOV and MFC with conventional parameters of ovarian reserve (age and basal and CC induced day 10 FSH and E 2 levels). Age per se demonstrated a negative correlation with basal inhibin B, MOV and MFC (r = −0.324, r = −0. 308, p < 0.05, and r = −0.527, p < 0.0001, respectively). There was a strong correlation between basal MOV and MFC (r = 0.613, p < 0.0001). Day 3 inhibin B demonstrated a slight negative correlation with both basal and day 10 FSH (r = −0.286 and r = −0.372, p < 0.05, respectively) and a positive correlation with MOV and MFC (r = 0.362 and r = 0.374, p < 0.001, respectively). Day 10 inhibin B demonstrated a negative correlation with day10 FSH (r = −0.527, p < 0.001) and a positive correlation with MOV and MFC (r = 0.423 and r = 0.418, p < 0.05, respectively). There was a statistically significant negative correlation between MOV, MFC, and basal FSH (r = −0.426 and r = −0.358, p < 0.001, respectively). MOV and MFC also demonstrated a slight negative correlation with day 10 FSH (r = −0.356 and r = −0.359, p < 0.05, respectively). There was not any significant correlation between day 3 and day 10 E 2 levels and other demographic, hormonal, and ultrasound variables.
To test the relation between hormonal and ultrasound parameters of ovarian reserve and the patient's ART performance, we divided the patients into subgroups as poor and good responders. Nine cycles were cancelled because of poor ovarian response to gonadotropin stimulation in poor responders. Twenty-three patients underwent oocyte aspiration and 21 patients had embryo transfer. Poor responders were relatively older, had higher FSH and lower inhibin B levels in day 3 and lower inhibin B levels in day 10 as compared to normal responders (Table II) . Although day 10 FSH levels were higher in poor responders as compared to normal responders, the difference did not reach significance. Thirteen of 32 patients (40.6%) revealed basal or CC induced FSH > 10 mIU/ mL. Eleven of 16 patients (68.7%) with poor ovarian response and two of 16 patients (12.5%) with normal ovarian response had basal or CC induced FSH > 10 mIU/mL. Day 3 and day 10 E 2 concentrations were not significantly different among groups; therefore, not reflective of either FSH/ inhibin B concentrations or ovarian response to gonadotropins and ART outcome. Patients with poor response had significantly lower MOV and MFC. Although the duration of gonadotrophin stimulation and amount of gonadotrophin ampoules did not differ among poor and normal responders, peak E 2 concentrations, the number of follicles punctured, the number of oocytes retrieved, and clinical pregnancy rates were significantly higher in the normal responders (Table II) . Patients who conceived were younger (31.3 ± 4.0) than the ones who did not (37.3 ± 4.4) ( p < 0.05). Although basal and CC induced hormonal parameters were not different between two groups, pregnant patients significantly had higher MOV (4.3 ± 1.0 vs. 2.9 ± 1.5, p < 0.05) and MFC (5.0 ± 1.3 vs. 3.0 ± 1.9, p < 0.05) estimations. Table III shows multiple logistic regression analysis and effects of variables to predict poor response to ovarian stimulation. Ovarian volume was better than other hormonal and ultrasound variables in predicting poor response to ovarian stimulation. The combination of hormonal parameters did not improve the odds ratio of ovarian volume for predicting ovarian response; however, MOV was found to be dependent on age and MFC (data not shown). When day 3 and day 10 FSH levels were analyzed together, abnormal CCCT was the only independent and significant factor in predicting ovarian response. The analysis of the impact of variables to predict pregnancy showed that age and MFC were equally better than each of MOV, basal FSH, and inhibin B in predicting pregnancy. However, age was found to be the only independent predictor of pregnancy (OR = 0.72; 95% CI = 0.53-0.99; sensitivity = 75.0; specificity = 85.0; and prognostic reliability = 81.25%).
The receiver operator characteristic curves and area under curve indicated that ovarian volume was the most accurate of the six variables assessed (Table IV) . The cut-off point for ovarian volume in discriminating the best between poor and normal ovarian response cycles was 2.98 mm 3 with a sensitivity of 75% and a specificity of 81.2%. The mean basal serum inhibin B was lower and basal FSH was higher in patients who had an IVF cycle and whose ovarian volume was <2.98 cm 3 (Table V) . Day 10 serum inhibin B and FSH levels were not statistically different between groups with ovarian volumes above or below this cut-off value. A lower antral follicle count was obtained for patients having ovarian volume <2.98 cm 3 as compared to patients having ovarian volume >2.98 cm 3 . On the other hand, the clinical pregnancy rate-the ultimate goal of treatment-was significantly higher in patients with ovarian volume >2.98 cm 3 than others with smaller ovaries.
DISCUSSION
The IVF outcome is related to ovarian response to gonadotropin stimulation; poor ovarian response with less oocytes retrieved and embryos available for transfer reduces the outcome of treatment. Poor response to ovarian stimulation is often age related, but may also occur in young patients. Various screening tests including age, basal FSH concentrations on day 3 of the menstrual cycle and CCCT have been developed to assess the ovarian reserve and to predict ovarian response to gonadotropin stimulation as well as pregnancy rates in IVF. All of these tests are indirect measurements of ovarian reserve and have their own limitations. Inhibin B, a direct product of granulosa cells which might indicate the number of developing follicles, has been suggested as a direct biochemical marker of ovarian reserve (12, 24) . Recently, transvaginal ultrasound measurement of early follicular phase ovarian antral follicle counts and ovarian volume has been used to predict the response to ovulation induction in infertile women (14, 15) . To our knowledge, this is the first study designed to compare both hormonal and ultrasound parameters of ovarian reserve with basal and CC induced inhibin B concentrations.
The current data clearly indicated that, in a population of infertile women with various ages, basal and CC induced day 10 inhibin B concentrations were lower in patients with diminished ovarian reserve manifested by abnormal CCCT as compared to patients with normal ovarian reserve. Moreover, basal and day 10 inhibin B correlated not only with basal and day 10 FSH but also with MOV and MFC. Although the mean age of two groups were not of similar and the sample size is small to be able to have adequate sensitivity to detect diminished ovarian reserve based on basal inhibin B levels, our findings were consistent with the results of a study by Hofmann et al. who found that day 3 and day 10 inhibin B concentrations were higher in patients with normal CCCT than those with diminished ovarian reserve (24) . They also showed that day 3 and day 10 inhibin B concentrations were correlated with basal and day 10 FSH concentrations. Others, in a recent study, failed to find these correlations and concluded that although CCCT was useful as a test of ovarian reserve, there was no additional value for inhibin B testing (13) . Aging women have increasing levels of FSH during early follicular phase, which in turn might be a consequence of declining secretion of inhibin by reduced number of ovarian follicles (8, 25, 26) . Patients with high serum levels of FSH on day 3 had granulosa cells of diminished capacity for secreting dimeric inhibins (9) . Furthermore, women with declining ovarian reserve had decreased day 3 serum inhibin B levels despite having normal day 3 basal FSH levels (12) . Inhibin B was found to be inversely correlated with age and FSH in women 39-52 years of age with regular menstrual cycles (10) . These data strongly suggest that inhibin B is a direct marker of ovarian reserve, and correlates well with other ovarian reserve tests including ovarian volume and antral follicle counts.
There are apparent discrepancies in the definition of poor response to ovarian stimulation with gonadotropins in different studies. In this study, the parameters of poor ovarian response to gonadotropin stimulation were a combination of number of oocytes retrieved (<5 MII oocytes) and peak estradiol concentration achieved (<1000 pg/mL); patients with cancelled cycles due to were also regarded as poor responder. The current study showed that: i) poor responders had lower basal and CC induced inhibin B and higher basal FSH, and lower MOV and MFC; ii) ovarian volume was a better predictor of ovarian response as compared to age, number of antral follicles, basal FSH and inhibin B, but abnormal CCCT was the only independent and significant parameter in predicting ovarian response; iii) age and antral follicle counts were better than ovarian volume and hormone measurements in predicting pregnancy, while age per se was independently related to pregnancy.
Cycle day 3 serum FSH concentration is an indirect measure of the amount of inhibin B and estradiol produced by a cohort of growing follicles and their feedback effects at the pituitary level. Although it has been described that cycle day 3 FSH concentration could predict ART outcome better than age (2), others failed to show such a correlation confirming our result (5) . Basal concentration of inhibin B has also been found to predict ovarian response in IVF treatment (11, 21) . It has been reported that women with low day 3 inhibin B levels (<45 pg/mL) had poor response to ovulation induction, lower estradiol on day of hCG and lower number of oocytes retrieved per patient, and were less likely to become pregnant than women with high inhibin B levels (≥45 pg/mL) (11). However, Corson et al., whose population included patients being treated only by conventional methods other than IVF, failed to find a difference in pregnancy rates using the same cut-off value (45 pg/mL) for inhibin B (13) . Moreover, it has been shown that age and the number of the oocytes retrieved were the strongest predictors of success; and only a combination of lower FSH (FSH <11.22 mIU/mL) and higher inhibin B (inhibin B ≥76.5 pg/mL) was associated with a greater chance for a successful outcome in IVF (21) . In a recent study, basal FSH level was reported to be significant and better predictor of cycle cancellation when compared with age and inhibin B, while age was better than both FSH and inhibin B levels in predicting pregnancy (27) . Consequently, on the basis of our data and others, it may be suggested that basal inhibin B is not a better predictor of ovarian response than age and basal FSH (21, 27) . It should also be taken into consideration that there is no international assay standard for inhibin B yet, and comparison of different inhibin B values between various studies seems to be a problem.
An important feature of the present study was that abnormal CC test was significant, independent and stronger predictor of ovarian response than all other hormonal variables. In this study, the percentage of patients (18.7%) with basal FSH concentrations ≥10 mIU/mL. increased to 40.6% when CCCT was performed which indicated that a significant number of patients with restricted ovarian reserve would have been missed if the challenge test was not applied. Our data are in concordance with earlier studies reporting CCCT as being more sensitive than day 3 FSH alone in predicting both cycle cancellation and pregnancy rates (2, 28, 29) . In one study, approximately twice as many patients were identified by using CCCT as compared to basal FSH screening alone and the cancellation rate was found to be higher in women with abnormal test results (29) . Loumaye et al. evaluated CCCT by defining a threshold value of 26 IU/L as the sum of cycle day 3 and 10 FSH values and concluded that predictive value of an abnormal test for failing to conceive was 100% (28) . Recently, it was reported that an abnormal CCCT had a positive predictive value of 93% for pregnancy and a negative predictive value of 80% for cycle cancellation (30) . Furthermore, it was reported in a biopsy study that CCCT was the most accurate to reflect follicular density as compared to basal FSH and gonadotropin-releasing hormone agonist test (31) . These results strongly indicate that clomiphene citrate challenge test may detect more patients with diminished ovarian reserve and predict ovarian response to gonadotropin stimulation better than basal FSH and inhibin B within an ART population.
In our study, ROC analysis revealed that ovarian volume was the most accurate of all tests in predicting poor response to ovarian stimulation. Our cut-off point for ovarian volume that discriminated the poor and normal responder was 2.98 cm 3 with a sensitivity of 75% and specificity of 81.2%. The results of the current study, as well as those reported by others, do support that ovarian volume, measured by transvaginal ultrasound, has been correlated well with response to ovulation induction in ART cycles (18) (19) (20) 32) . Small ovaries (<3 cm 3 ) were found to predict poor response to ovarian stimulation and high cancellation rates but not pregnancy achievement (19) . It was also reported that a significant decrease in the number of follicles and a higher cancellation rate observed in women with ovarian volume smaller than 3 cm 3 (18) . In a previous report, it was shown that total ovarian volume but not basal FSH was a predictor of cycle cancellation and volume of the smallest ovary was a predictor of clinical pregnancy in IVF (32). Our results indicated that antral follicle counts and age were better measures than ovarian volume and hormones for predicting pregnancy in IVF. Others also found that number of antral follicles was related to age, number of oocytes retrieved, and cycle cancellations (14) (15) (16) 33, 34) . Nevertheless, the general trend in the literature is such that age is an independent parameter in predicting pregnancy, certainly better than ultrasound and hormonal tests of ovarian reserve (21, 27) . More studies are needed to draw definitive conclusions regarding follicle count and pregnancy association.
CONCLUSIONS
In summary, although basal and clomiphenestimulated inhibin B concentrations correlated well with other ovarian reserve tests in a relatively small sample size of infertile population, inhibin B was not predictive of either ovarian response to gonadotropin stimulation or pregnancy rates in ART cycles. In addition, difficulties in standardization of the hormone measurements as well as lack of uniformity between different studies limit the widespread use of inhibin B as an ovarian reserve test. Ultrasound measurement of ovarian volume were better than age and basal hormone levels (FSH and inhibin B) in discriminating cycles with poor response while antral follicle counts and age were better in predicting pregnancy. However, clomiphene citrate challenge test, as a more sensitive dynamic test of ovarian reserve, provided more information in predicting ovarian response to gonadotropin stimulation in ART cycles. Clomiphene citrate challenge test and transvaginal ovarian measurements can practically be used to predict poor response to ovarian stimulation in ART cycles, thereby allowing physicians to inform patients about their risk for poor ovarian stimulation and cycle cancellation.
